Redirect Notice
 The previous page is sending you to https://www.businesswire.com/news/home/20240320953949/en/Avenacy-Announces-Launch-of-Furosemide-for-Injection-in-the-U.S.-Market.

 If you do not want to visit that page, you can return to the previous page.